Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health, Inc. (NYSE: TDOC) is described as the global leader in virtual care, and the news surrounding the company reflects its focus on virtual urgent care, integrated care programs and financial performance. Company news includes announcements about enhancements to its 24/7 Care service, participation in major healthcare investor conferences, quarterly earnings results and leadership changes.
Recent updates highlight Teladoc Health’s work to expand its flagship 24/7 Care virtual urgent care service. The company has announced new capabilities that allow licensed care providers to treat a broader range of conditions, consult with board-certified specialists during visits, support preventive care using integrated claims and Health Information Exchange data, connect members to additional Teladoc Health programs and in-network providers, and check prescription benefits in real time through its Prism care delivery platform.
Investors and analysts can also find earnings-related news, including quarterly financial results for the Integrated Care and BetterHelp segments, revenue by type and geography, and non-GAAP measures such as adjusted EBITDA. Teladoc Health regularly issues press releases about its financial outlook, cash flow, and capital structure decisions, including the establishment of a senior secured revolving credit facility.
Other news items cover corporate governance and leadership developments, such as executive transitions and Board changes, as well as Teladoc Health’s participation in industry conferences and collaborations with other virtual care technology providers. This news page aggregates these updates so readers can follow Teladoc Health’s operational, strategic and financial developments over time.
Teladoc Health (TDOC) reported a remarkable 151% revenue growth to $453.7 million for Q1 2021, boosted by a 56% increase in total visits to 3.2 million. The company also tripled the number of consumers enrolled in chronic care programs year-over-year. Despite these gains, it faced a net loss of $199.6 million, largely due to stock-based compensation and amortization from acquisitions. For FY 2021, Teladoc raised its revenue guidance to $1.97 billion - $2.02 billion, maintaining a focus on whole-person care integration.
Teladoc Health (NYSE: TDOC) has appointed Claus Jensen as chief innovation officer to enhance its research and development efforts. Jensen, who has over 20 years of experience in digital transformation at leading healthcare organizations, previously served as chief digital officer at Memorial Sloan Kettering Cancer Center. His expertise includes product innovation, health informatics, and data products. This strategic hire is aimed at accelerating Teladoc's vision of seamless healthcare solutions from hospitals to home, leveraging technology and data insights to improve patient care.
Teladoc Health (NYSE: TDOC) is set to announce its first-quarter 2021 results on April 28, 2021, after market close. The company will host a conference call at 4:30 p.m. E.T. to discuss the results. Interested participants can join by dialing designated numbers or via a live audio webcast accessible online. The recording will be available for approximately 90 days post-call. As a leader in virtual care, Teladoc Health focuses on enhancing health outcomes through innovative, personalized healthcare experiences.
Caption Health has appointed Steve Cashman as the new President and CEO, effective immediately. Cashman previously served as Chief Commercial Officer at InTouch Health, which was acquired by Teladoc (NYSE: TDOC) in 2020. Under his leadership, InTouch achieved a 35% year-over-year growth in 2019. Cashman aims to enhance ultrasound accessibility in healthcare, supported by a $4.95M grant from the Gates Foundation for lung ultrasound AI development. The company has also added new leaders in marketing, finance, and operations, aiming for innovative growth in medical imaging.
Teladoc Health (TDOC) reported a significant growth in Q4 2020, with revenue soaring 145% year-over-year to $383.3 million and total visits rising 139% to 3.0 million. For the full year, revenue grew 98% to $1,094 million, with total visits increasing 156% to 10.6 million. Despite these gains, the net loss for Q4 was $(394.0 million), up from $(19.0 million) in Q4 2019, impacted by acquisition costs and stock-based compensation. Looking ahead, the company provided Q1 2021 revenue guidance of $445 million to $455 million.
Teladoc Health (NYSE: TDOC) announces participation in the Cowen Healthcare Conference on March 2, 2021, featuring CEO Jason Gorevic and CFO Mala Murthy at 12:50 p.m. ET. A live audio webcast and replay will be accessible on their investor relations website.
Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health is a leader in whole-person virtual care, utilizing proprietary health signals to enhance health outcomes. The company focuses on transforming the healthcare experience for improved consumer and professional engagement.
Teladoc Health, Inc. (NYSE: TDOC) is offering free, 24/7 telehealth visits to residents in Oklahoma and Texas affected by winter storms. Displaced individuals can access treatment for non-emergency illnesses by calling 855-225-5032. The initiative aims to enhance access to healthcare during electricity and heat loss due to extreme weather and the ongoing pandemic. Services include consultations for common conditions and COVID-19 screening. For more info, visit teladoc.com/disaster-hotline.
Teladoc Health (TDOC) will announce its fourth-quarter and full-year 2020 financial results on February 24, 2021, after market close. A conference call will follow at 4:30 p.m. E.T. for a detailed review of the results. Participants can join by phone or via a live audio webcast. Teladoc Health is recognized as a leader in whole-person virtual care, leveraging over a decade of insights and expertise to improve healthcare outcomes. For more details, visit the official website.
Teladoc Health released its inaugural Corporate Social Responsibility (CSR) Report, emphasizing its commitment to equitable healthcare access, responsibility, and community impact. In 2020, Teladoc provided over 10 million virtual visits, assisting over 2 million members in underserved areas. The report outlines efforts to enhance healthcare capacity during COVID-19, reduce CO2 emissions by 5,000 metric tons per million virtual visits, and promote a diverse workplace. Additionally, the company contributed $700,000 to global health initiatives.
Teladoc Health and DexCom announced a partnership to enhance diabetes management for Type 2 diabetes patients. Joint members of Livongo for Diabetes will receive new CGM-powered insights that integrate Dexcom’s continuous glucose monitoring data with additional health signals from Teladoc. This offering aims to empower users with actionable health recommendations and will be piloted at no cost to eligible members in 2021. The collaboration highlights a rising trend in diabetes, with estimates suggesting 463 million adults currently affected globally.